EP2680810A2 - Déodorants et anti-transpirants respectueux de la peau - Google Patents

Déodorants et anti-transpirants respectueux de la peau

Info

Publication number
EP2680810A2
EP2680810A2 EP11711911.5A EP11711911A EP2680810A2 EP 2680810 A2 EP2680810 A2 EP 2680810A2 EP 11711911 A EP11711911 A EP 11711911A EP 2680810 A2 EP2680810 A2 EP 2680810A2
Authority
EP
European Patent Office
Prior art keywords
deodorant
weight
group
antiperspirant
composition according
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP11711911.5A
Other languages
German (de)
English (en)
Inventor
Astrid Kleen
Susanne Hagenow
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Henkel AG and Co KGaA
Original Assignee
Henkel AG and Co KGaA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Henkel AG and Co KGaA filed Critical Henkel AG and Co KGaA
Publication of EP2680810A2 publication Critical patent/EP2680810A2/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q15/00—Anti-perspirants or body deodorants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A61K8/25—Silicon; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A61K8/26—Aluminium; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/34—Alcohols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4906—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom
    • A61K8/4926—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom having six membered rings

Definitions

  • the present invention relates to cosmetic and dermatological antiperspirant and deodorant compositions which have a skin-friendly and caring effect.
  • antiperspirant compositions hereinafter also referred to as antiperspirants, contain as antiperspirant active ingredient at least one water-soluble astringent inorganic and organic salts of aluminum, zinc or selected aluminum-zirconium mixed salts.
  • deodorant compositions also referred to below as deodorants, frequently contain at least one antibacterial active substance as the deodorant active ingredient.
  • the antiperspirant active ingredients have no direct influence on the activity of the sweat glands, but minimize the narrowing of the discharge channels sweat secretion.
  • the AI salts cause thereby on the treated skin surfaces a sweat inhibition by superficial blockage of the sweat gland ducts as a result of Al-Mucopolysaccharid precipitation.
  • Antiperspirant and deodorant compositions are usually applied and applied in the forearm region or in the region of the armpits. The skin in this area is usually more sensitive than the rest of the body's skin, often at least as sensitive as the skin on the face. There is therefore a constant need for particularly skin-compatible formulations which are suitable as carriers for cosmetic and dermatological antiperspirant and deodorant compositions.
  • the object of the present invention was to provide agents that develop a long-term storage times a soothing and nourishing effect, without resulting in a deterioration of the care effect of deodorant and antiperspirant active ingredients.
  • the care substances should also be able to be used together with other active enhancers and hair growth inhibiting substances, without falling in their performance and without having to sacrifice the level of care-free products.
  • skin care and soothing cosmetic or dermatological deodorant or antiperspirant compositions with at least one deodorant or antiperspirant active ingredient and at least one substituted cyclohexanol can be improved in performance if they contain at least one deo-adjuvant from the groups of silver salts and / or silver complexes and / or minerals of volcanic origin and / or zeolites and / or alum and / or hair growth inhibiting agents.
  • compositions containing frans-4-ferf-butyl-cyclohexanol are known, for example, from WO2009 / 087242 A2.
  • Examples 32-36 also disclose deodorant compositions, without, however, going into potentizing minerals, salts or hair growth inhibitors.
  • the present application therefore relates to cosmetic or dermatological deodorant or antiperspirant compositions containing in a cosmetically or dermatologically acceptable carrier
  • the term “skin” generally refers to the skin itself, the mucous membrane and the skin appendages, insofar as they comprise living cells, in particular hair follicles, hair roots, hair bulbs, the anterior epithelium of the nail bed (lectorulus) as well as sebaceous glands and sweat glands.
  • skin is to be understood as meaning the "human skin”.
  • preferred antiperspirant active substances are selected from aluminum chlorohydrates, especially aluminum chlorohydrates having the general formula [Al 2 (OH) 5 CI 2-3 ⁇ H 2 0] n, which may be present in non-activated or activated in (depolymerized) Form , further aluminum sesquichlorohydrate, aluminum chlorohydrex propylene glycol (PG) or aluminum chlorohydrex-polyethylene glycol (PEG), aluminum sesquichlorohydrex PG or PEG, aluminum PG-dichlorhydrex or aluminum PEG-dichlorhydrex, aluminum hydroxide, further selected from the aluminum zirconium chlorohydrates, such as aluminum zirconium trichlorohydrate, aluminum zirconium tetrachlorohydrate, aluminum zirconium pentachlorohydrate, aluminum zirconium octachlorohydrate, the aluminum zirconium chlorohydrate, the aluminum zirconium trichlorohydrate, aluminum zirconium tetrachlorohydrate, aluminum zi
  • water solubility is understood as meaning a solubility of at least 5% by weight at 20 ° C., that is to say amounts of at least 5 g of the antiperspirant active are soluble in 95 g of water at 20 ° C.
  • the antiperspirant active ingredients can be used as aqueous solutions.
  • compositions according to the invention are characterized in that the at least one antiperspirant active ingredient is present in a total amount of 3 to 25 wt.%, Preferably 5 to 22 wt.% And in particular 10 to 20 wt. is contained, based on the total weight of the active substance according to USP in the overall composition.
  • the composition comprises an astringent aluminum salt, especially aluminum chlorohydrate, for example, in powder form as Micro Dry ® Ultrafine from Reheis, in the form of an aqueous solution as Locron ® L from Clariant, as Chlorhydrol ® as well as in activated form as Reach ® 501 Reheis is distributed.
  • compositions according to the invention can contain both at least one deodorant and at least one antiperspirant active ingredient.
  • Deodorant active ingredients which are preferred according to the invention are silicates, zinc ricinoleate, cyclodextrins, organic germ-inhibiting agents, prebiotic active components and also enzyme inhibitors or, in particular, combinations of the active substances mentioned.
  • silicates which are particularly preferred according to the invention are, in particular, phyllosilicates and, among these, in particular montmorillonite, kaolinite, mit, beidellite, nontronite, saponite, hectorite, benitite, smectite and talcum. They are preferably in an amount of 0.1 to 10 wt .-%, especially preferably 0.5 to 7 wt .-% and exceptionally 1 to 5 wt .-%, each based on the total composition used.
  • Zinkricinoleat is also preferably in an amount of 0.5 to 7 wt .-% and most preferably 1-5 wt .-%, each based on the total composition included.
  • cyclodextrins are preferably in a total amount of 0.5 to 7 wt .-% and most preferably 1-5 wt .-%, each based on the total composition included.
  • organic germ-inhibiting or antimicrobial active ingredients are understood as meaning those organic active substances which reduce the number of skin germs participating in the formation of the odor or inhibit their growth.
  • These organisms include, among others, various species from the group of staphylococci, the group of Corynebacteria, anaerococci and micrococci.
  • organic germ-inhibiting or antimicrobial agents are particularly preferred organohalogen compounds and quaternary ammonium compounds, a number of plant extracts and organic zinc compounds.
  • organohalogen compounds and quaternary ammonium compounds a number of plant extracts and organic zinc compounds.
  • These include triclosan, chlorhexidine and chlorhexidine gluconate, 3,4,4'-trichlorocarbanilide, bromochlorophene, dichlorophen, chlorothymol, chloroxylenol, hexachlorophene, dichloro-m-xylenol, dequalinium chloride, domibromium bromide, ammonium phenolsulfonate, benzalkonium halides, benzalkonium cetyl phosphate, benzalkonium saccharinates, benzethonium chloride, Cetylpyridinium chloride, laurylpyridinium chloride, laurylisoquinolinium bromide,
  • phenol phenoxyethanol, disodium dihydroxyethylsulfosuccinyl undecylenate, zinc lactate, sodium phenolsulfonate and zinc phenolsulfonate, ketoglutaric acid, terpene alcohols such.
  • chlorophyllin copper complexes alpha-monoalkyl glycerol ether with a branched or linear saturated or unsaturated, optionally hydroxylated C 6 - C 22 alkyl, particularly preferably alpha- (2-ethylhexyl) glycerol ether, commercially available as Sensiva ® SC 50 (ex Schülke & Mayr), carboxylic acid esters of mono-, di- and triglycerin (eg glycerol monolaurate, diglycerol monocaprate) and plant extracts (eg green tea and components of lime blossom oil) are preferred.
  • deodorant active substances are selected from so-called prebiotic active components, which according to the invention are to be understood as meaning those components which inhibit only or at least predominantly the odor-causing germs of the skin microflora, but not the desired ones, that is to say the non-odor-causing germs belonging to a healthy skin microflora.
  • prebiotic active components especially from the group of Pinaceae, and plant extracts from the group of Sapindaceae, Araliaceae, Lamiaceae and Saxifragaceae, in particular extracts of Picea spp., Paullinia sp., Panax sp., Lamium album or Ribes nigrum and mixtures thereof substances.
  • the enzyme inhibitors include substances which inhibit the enzymes responsible for the sweat decomposition, in particular arylsulfatase, beta-glucuronidase, aminoacylase, esterases, lipases and / or lipoxigenase, e.g. B. trialkylcitric acid, in particular triethyl citrate, or zinc glycinate.
  • Preferred deodorant or antiperspirant compositions according to the invention are characterized in that the at least one deodorant active ingredient is selected from arylsulfatase inhibitors, beta-glucuronidase inhibitors, aminoacylase inhibitors, esterase inhibitors, lipase inhibitors and lipoxigenase inhibitors, alpha Monoalkylglycerinethern with a branched or linear saturated or unsaturated, optionally hydroxylated C 6 - C 2 2-alkyl radical, in particular alpha- (2-ethylhexyl) glycerol ether, phenoxyethanol, prebiotic components, trialkylcitric acid esters, in particular triethyl citrate, active compounds which have the number of on the Odor-forming skin bacteria from the group of staphylococci, Corynebacteria, anaerococci and micrococci reduce or inhibit their growth, organic zinc compounds, especially zinc phenolsulfonate and Zinkricinoleat, Organohalogentagen
  • deodorant or antiperspirant compositions are characterized in that the at least one deodorant active ingredient is present in a total amount of 0.1-10% by weight, preferably 0.2-7% by weight, particularly preferably 0.3 - 5 wt .-% and most preferably 0.4 - 1, 0 wt .-%, each based on the total weight of the active substance of the deodorant active ingredient or the deodorant active ingredients in the overall composition is included.
  • compositions according to the invention contain frans-4-hept-butyl-cyclohexanol.
  • frans-4-ferf-butyl-cyclohexanol encompasses both the (+) - frans-4-ferf-butyl-cyclohexanol of the formula (I) and the (-) - frans-4-ferf Butyl-cyclohexanol of the formula (II) and mixtures thereof, in particular their racemic mixture.
  • Particularly preferred deodorant or antiperspirant compositions according to the invention are characterized in that they contain, based on their weight, from 0.05 to 10% by weight, preferably from 0.1 to 7.5% by weight, more preferably from 0.25 to 5 wt .-%, particularly preferably 0.5 to 2.5 and in particular 0.6 to 1, 25 wt .-% frans-4-ferf-butyl-cyclohexanol.
  • the agents according to the invention are enhanced in performance by the addition of deodorant adjuvants without losing their advantageous properties in terms of skin care and skin care.
  • They contain at least one deodorant adjuvant from the groups of silver salts and / or silver complexes and / or minerals of volcanic origin and / or zeolites and / or alum and / or hair growth-inhibiting active ingredients. In this way it is possible to provide means with superior performance level with optimal care properties.
  • silver salts and / or silver complexes in particular silver nitrate, silver acetate, silver sulfate and silver citrate are suitable; silver citrate-citric acid complexes of the formula are also preferred
  • silver lactate and / or silver lactate-lactic acid complexes of the form are also suitable
  • compositions according to the invention are characterized in that silver lactate is present in a total amount of 1.8 to 182 ppm, preferably 3.6 to 91.3 ppm, more preferably 9.6 to 35.5 ppm, most preferably 12.8 to 18.3 ppm, in each case based on the weight of the composition according to the invention.
  • compositions according to the invention are characterized in that silver acetate in a total amount of 1.5-154.7 ppm, preferably 3.1-77.4 ppm, more preferably 7.7-30.9 ppm, most preferably 10.8-15 , 5 ppm, in each case based on the weight of the composition according to the invention.
  • silver sulfate and / or silver sulfate-sulfuric acid complexes of the form are also suitable
  • compositions according to the invention are characterized in that silver sulfate in a total amount of 1.4 to 145 ppm, preferably 2.9 to 72.3 ppm, more preferably 7.2 to 28.9 ppm, most preferably 10.1 to 14.5 ppm, in each case based on the weight of the composition according to the invention.
  • silver malate and / or silver malate-hydroxysuccinic acid complexes of the form are also suitable or the form
  • compositions according to the invention are characterized in that silver malate is present in a total amount of 1.6-161.2 ppm, preferably 3.2-80.6 ppm, more preferably 8.1-32.2 ppm, most preferably 11, 3-16.1 ppm, each based on the weight of the composition according to the invention is included.
  • silver succinate and / or silver succinate succinic acid complexes of the form are also suitable
  • compositions according to the invention are characterized in that silver succinate is present in a total amount of 1.5-15.3.8 ppm, preferably 3. 1-76.9 ppm, more preferably 7.7-30.8 ppm, most preferably 10.8-15 , 4 ppm, in each case based on the weight of the composition according to the invention.
  • silver tartrate and / or silver tartrate-tartaric acid complexes of the form are also suitable
  • compositions according to the invention are characterized in that silver tartrate in a total amount of 1.7-168.6 ppm, preferably 3.4-84.3 ppm, more preferably 8.4-33.7 ppm, most preferably 1 1, 8 16.9 ppm, in each case based on the weight of the composition according to the invention, is contained.
  • silver mandelate and / or silver mandelate-mandelic acid complexes are also of the form
  • compositions according to the invention are characterized in that silver mandelate in a total amount of 2.4-240, 1 ppm, preferably 4.8-120 ppm, particularly preferably 12-48 ppm, most preferably 16.8-24 ppm, in each case based on the Weight of the composition of the invention is included.
  • silver salicylate and / or silver salicylate-salicylic acid complexes of the form are also suitable
  • compositions according to the invention are characterized in that silver salicylate in a total amount of 2.3-222.1 ppm, preferably 4.5-1 13.6 ppm, more preferably 11-45.4 ppm, most preferably 15.9 - 22.7 ppm, in each case based on the weight of the composition according to the invention is contained.
  • silver gluconate and / or silver gluconate-gluconic acid complexes of the form are also suitable
  • compositions according to the invention are characterized in that silver gluconate in a total amount of 2.8-280.9 ppm, preferably 5.6-140.4 ppm, more preferably 14-56.2 ppm, most preferably 19.7-28.1 ppm, in each case based on the weight of the composition according to the invention.
  • compositions of the present invention which, by weight, contain silver ions in a total amount of 1-100 ppm , preferably 2 - 50 ppm, more preferably 5 - 20 ppm, most preferably 7 - 10 ppm, each based on the weight of the composition according to the invention.
  • compositions according to the invention contain one or more deodorant adjuvants from the groups of minerals of volcanic origin and / or zeolites and / or alum and / or the hair growth-inhibiting active ingredients.
  • volcanics Minerals of volcanic origin, so-called volcanics, are magmatic rocks that have risen as molten magma, flowed out by volcanoes and solidified (eruptive, effusive, effusion, extrusive rocks). As a result of the rapid cooling, the volcanics are usually finely crystalline; they may contain vitreous components in the matrix or may even be completely glassy (eg obsidian, pumice stone). Feldspars are essential components in almost all volcanics.
  • perlite As mineral of volcanic origin, in the context of the present invention, in particular perlite (perlite) have proven to be suitable. Perlites are light gray, also black volcanic rock glass of rhyolite composition with 70-76% Si0 2 , 1 1-18% Al 2 0 3 , 4-6% K 2 0 u. 2-7% water. Regardless of which volcanic rock (s) are used in the compositions of the present invention, preference is given to deodorant or antiperspirant compositions according to the invention which, by weight, are from 0.05 to 15% by weight, preferably 0.1 to 12.5% by weight, more preferably 0.25 to 10% by weight, particularly preferably 0.5 to 7.5 and in particular 0.6 to 5% by weight of minerals of volcanic origin, in particular perlite , contain.
  • the natural zeolites can be classified into fiber zeolites (natrolite, laumontite, mordenite, thomsonite), zeolite zeolites (heulandite, stilbite, phillipsite, harmotom, yugawa ralith) and the so-called cube zeolites (faujasite, gmelinite, chabazite, offretite, levyn) that have a cubic or pseudocubic lattice.
  • fiber zeolites natrolite, laumontite, mordenite, thomsonite
  • zeolite zeolites heulandite, stilbite, phillipsite, harmotom, yugawa ralith
  • cube zeolites faujasite, gmelinite, chabazite, offretite, levyn
  • the synthetic zeolites are divided into pore sizes in narrow, medium and wide pore types. Within this group there are more than 150 different framework structures, which often differ in the Si / Al ratio (modulus).
  • synthetic zeolites were first given trivial names: zeolite A [modulus 2, pore size 0.4 nm (Na)], zeolite X [modulus 2-3, pore size 0.7 nm (Na)], zeolite Y [Module 3-6, pore size 0.7 nm (Na)], zeolite L [modulus 6-10, pore size 0.7 nm (K)], synthetic mordenite (modulus about 10, pore size 0.7 nm).
  • IZA International Zeolite Association
  • MOR stands for mordenite or BEA for zeolite beta.
  • deodorant or antiperspirant compositions according to the invention which, based on their weight, are from 0.05 to 15% by weight, preferably from 0 to 1 10 wt .-%, more preferably 0.25 to 5 wt .-%, particularly preferably 0.5 to 2 and in particular 0.6 to 1 wt .-% zeolites.
  • compositions of the invention may contain at least one double salt of the alum type having the general formula M l M l "(S0 4) 2 x H 2 0 ⁇ contain, where M 1 is a monovalent cation selected from potassium, sodium, rubidium, Cesium and ammonium ions, M 1 "is a trivalent cation selected from aluminum, gallium, indium, scandium, titanium and vanadium ions, and x is a rational number in the range of 0 to 12, including 0, represent.
  • KAI (S0 4 ) 2 KAI (S0 4 ) 2 , KAI (S0 4 ) 2 ⁇ 1 H 2 0, KAI (S0 4 ) 2 ⁇ 2 H 2 0, KAI (S0 4 ) 2 ⁇ 3 H 2 0, KAI (S0 4 ) 2 ⁇ 4 H 2 0, KAI (S0 4 ) 2 ⁇ 5 H 2 0, KAI (S0 4 ) 2 ⁇ 6 H 2 0, KAI (S0 4 ) 2 ⁇ 7 H 2 0, KAI (S0 4 ) 2 ⁇ 8 H 2 0, KAI (S0 4 ) 2 ⁇ 9 H 2 0, KAI (S0 4 ) 2 ⁇ 10 H 2 0, KAI (S0 4 ) 2 ⁇ 11 H 2 0 and KAI (S0 4 ) 2 ⁇ 12 H 2 0.
  • Salts with a water content of less than 12 molecules per molecule of alum are produced by heating alum. From a temperature of about 60 ° C up to 25% of the water of crystallization already escape, preferred temperatures for further dewatering are 500 ° C or less, preferably 300 ° C or less, more preferably 250 ° C or less, most preferably 200 ° C or less, most preferably 90-150 ° C.
  • Completely dewatered alum (also called fired alum) or partially dewatered alum may, at least in higher concentrations, disperse better than alums having a water content of less than 12 molecules per molecule and may therefore be preferred for the compositions of this invention.
  • alum particles are preferred which have a number average particle size of 0.1-150 ⁇ , preferably 1-80 ⁇ , more preferably 5-60 ⁇ and exceptionally preferably 10-30 ⁇ .
  • alum (s) are used in the compositions according to the invention
  • preference is given to deodorant or antiperspirant compositions according to the invention which, based on their weight, are from 0.05 to 10% by weight, preferably from 0.1 to 5 wt .-%, more preferably 0.2 to 3 wt .-%, particularly preferably 0.5 to 2 and in particular 0.7 to 1 wt .-% alum (s) included.
  • trans-4-tert-butyl-cyclohexanol particularly compatible hair growth inhibiting substances are derivatives of 3-hydroxy-4 (1 H) -pyridone and so-called advanced glycation endproducts (AGE).
  • AGE advanced glycation endproducts
  • Agents preferred according to the invention comprise at least one derivative of the 3-hydroxy-4 (1H) -pyridone of the general formula (I)
  • the radical R 1 is a C 1 -C 6 -alkyl group, a C 2 -C 6 -alkenyl group, a C 2 -C 6 -hydroxyalkyl group, a C 2 -C 6 -polyhydroxyalkyl group, a C 1 -C 6 -alkoxy-C 2 -C 6 alkyl group, a C-
  • n stands for a natural number of 2 to 6 in this context
  • the two radicals R2 and R3 independently of one another represent a hydrogen atom, a
  • R 1 and R 2 or R 1 and R 3 together may form a five- or six-membered saturated ring system which may optionally contain further heteroatoms or may carry further substituents,
  • the radical R4 contained in the substructure (7) is a C 1 -C 4 -alkyl group, a C 2 -C 6 -alkenyl group or a C 2 -C 6 -hydroxyalkyl group.
  • the radical R 1 in formula (I) can, in a preferred embodiment of the present invention, be a C 1-6 -alkyl group or a C 2 . 6 alkenyl group stand.
  • the radical R 1 can be a C 2 -C 6 -hydroxyalkyl group or a C 2 -C 6 -polyhydroxyalkyl group or a C 1 -C 6 -alkoxy-C 2 -C 6 -alkyl group.
  • compositions of this embodiment contain at least one derivative of the 3-hydroxy-4 (1 H) -pyridone of the general formula (I) in which the radical R 1 is a C 2 -C 6 -hydroxyalkyl group, a C 2 -C 6 -polyhydroxyalkyl group or a C 1 -C 6 -alkoxy-C 2 -C 6 -alkyl group, preferred for -CH 2 OH, - (CH 2 ) 3 OH, - (CH 2 ) (CHOH) CH 2 OH, - (CH 2 ) 2 (CHCOH) CH 2 OH, - (CH 2 ) 2 (CHCH 3 ) CH 2 OH, - (CH 2 ) 2 -O-CH 3 , - (CH 2 ) 2 -O-CH 2 -CH 3 , - (CH 2 ) 2 -O-CH 2 -CH 3 , - ( CH2) 3 -0-CH 3 or - (CH 2) 3 -0-CH 2 -CH
  • the radical R 1 can be a C 1 -C 6 -cyanoalkyl group, an aminoC 1 -C 6 -alkyl group or a di (C 1 -C 6 -alkyl) aminoC 2 -C 6 -alkyl group
  • Preferred deodorant or antiperspirant compositions of this embodiment according to the invention are characterized in that they comprise at least one derivative of the 3-hydroxy-4 (1H) -pyridone of the general formula (I) in which the radical R 1 is C 1-1 -C 6 cyanoalkyl group, an amino C 2 -C 6 alkyl group or a di- (C 1 -C 6 alkyl) aminoC 2 -C 6 alkyl group, preferably -CH 2 CN, - (CH 2 ) 2 CN, - (CH 2 ) 3 CN, - (CH 2 ) 2 NH 2 , - (CH 2 ) 3 NH 2 , - (CH 2 )
  • radical R1 compounds of general formula (I) are preferred in the invention, in which the radical R2 is a C-C ö alkyl group.
  • Preferred deodorant or antiperspirant compositions according to the invention comprise at least one derivative of the 3-hydroxy-4 (1H) -pyridone of the general formula (I) in which the radical R 2 is a C 1 -C 6 -alkyl group, preferably -CH 3 , -CH 2 CH 3 , - (CH 2 ) 2 CH 3 , -CH (CH 3 ) 2 , - (CH 2 ) 3 CH 3 , -C (CH 3 ) 3 , -CH 2 CH (CH 3 ) 2 , - (CH 2 ) 4 CH 3 , - (CH 2 ) 5 CH 3 and in particular represents a methyl group.
  • R 1 and R 2 compounds of general formula (I) are preferred, in which the radical R3 is -H or Ci-C ö alkyl group.
  • Preferred deodorant or antiperspirant compositions according to the invention therefore contain at least one derivative of the 3-hydroxy-4 (1H) -pyridone of the general formula (I) in which the radical R3 is -H.
  • R 1 in formula (I) is a C 1-6 -alkyl group or a C 2 . 6- alkenyl group
  • particularly preferred deodorant or antiperspirant compositions according to the invention are characterized in that they are used as derivatives of the 3-hydroxy-4 (1H) -pyridone of the general formula (I)
  • particularly preferred deodorant or antiperspirant compositions according to the invention are characterized in that they are used as derivatives of the 3-hydroxy-4 (1H) -pyridone of the general formula (I)
  • radical R 1 in formula (I) is a C 1 -C 6 -cyanoalkyl group, an aminoC 2 -C 6 -alkyl group or a di- (C 1 -C 6 -alkyl) amino-C 2 -C 6 -alkyl group
  • particularly preferred deodorant or antiperspirant compositions according to the invention are characterized in that they are used as derivatives of the 3-hydroxy-4 (1H) -pyridone of the general formula (I)
  • R1 may be selected from the structural units (2) to (10). Particularly preferred radicals R 1 are the structural units (2), (3), (4) or (8). In very particularly preferred compounds according to the invention of this embodiment, R 2 is -CH 3 and R 3 is simultaneously -H. Very particularly preferred deodorant or antiperspirant compositions according to the invention of this embodiment are therefore characterized in that they are used as derivatives of the 3-hydroxy-4 (1H) -pyridone of the general formula (I)
  • compositions according to the invention comprise a compound or a mixture of various compounds from the group of the derivative (e) of the 3-hydroxy-4 (1H) -pyridone of the general formula (I) from 0.00001 to 10% by weight. -% preferably from 0.0001 to 5 wt .-%, particularly preferably from 0.001 to 1 wt .-%, each based on the total composition.
  • Particularly preferred deodorant or antiperspirant compositions according to the invention contain, based on their weight, 0.00001 to 10% by weight, preferably 0.0001 to 5% by weight, particularly preferably 0.0005 to 2.5% by weight. , Further preferably 0.001 to 1 wt .-% and in particular 0.01 to 0.5 wt .-% derivative (s) of the 3-hydroxy-4 (1 H) -pyridone of the general formula (I).
  • deodorant or antiperspirant compositions contain - based on the weight of the ready-to-use composition - 0.00001 to 10 wt .-%, preferably 0.0001 to 5 wt .-%, particularly preferably 0.0005 to 2.5 wt .-%, more preferably 0.001 to 1 wt .-% and in particular 0.01 to 0.5 wt .-% of one or more compounds from the group
  • preferred deodorant or antiperspirant compositions contain, based on their weight, from 0.00001 to 10% by weight, preferably from 0.0001 to 5% by weight, particularly preferably from 0.0005 to 2.5% by weight. , more preferably 0.001 to 1 wt .-% and in particular 0.01 to 0.5 wt .-% derivative (s) of the 3-hydroxy-4 (1 H) -pyridone of the general formula (I)
  • the radical R 1 is a C
  • n stands for a natural number of 2 to 6 in this context
  • the two radicals R2 and R3 independently of one another represent a hydrogen atom, a
  • R 1 and R 2 or R 1 and R 3 together may form a five- or six-membered saturated ring system which may optionally contain further heteroatoms or may carry further substituents,
  • the radical R4 contained in the substructure (7) is a C 1 -C 4 -alkyl group, a C 2 -C 6 -alkenyl group or a C 2 -C 6 -hydroxyalkyl group.
  • the agents according to the invention may contain so-called AGEs.
  • AGE comes from the English term "advanced glycation endproducts".
  • AGEs are obtainable, for example, according to the following (exemplary) reaction equation:
  • the term "precursor" expressly does not mean the respective starting materials of the reaction, ie the unreacted starting materials.
  • Advantageous starting materials (I) carry an aldehyde group (CHO) and are chosen, for example, from the group of sugars (aldoses, eg trioses, tetroses, pentoses, hexoses and the like, such as glucose, galactose, mannose, etc.).
  • Advantageous starting materials (II) have a free amino group and are selected, for example, from the group of amino acids and the group of peptides having terminal amino groups, in particular lysine, hydroxylysine, arginine, tryptophan and histidine are advantageous.
  • the free amino group can also originate from N-terminal ends of proteins and peptides, and also advantageously sphingosine and dihydrosphingosine and their homologs with different lengths of (unsaturated) acyl radicals.
  • AGEs according to the invention preferably contain at least one nitrogen-containing and / or oxygen-containing five-membered and / or six-membered ring.
  • furan derivatives FFI and the furanone 2 which are distinguished by the following structural formulas:
  • pyranopyranones for example those of structural formula 5:
  • pyrrolinones for example those of the following structural formulas:
  • the radical R in the structural formulas 1, 3 and 4 preferably originates from proteins and peptides; Accordingly, these are preferably peptide, amino acid or protein residues which may be attached terminally or laterally to the nitrogen atom.
  • R is further advantageously selected from the group of saturated or unsaturated, branched or unbranched alkyl groups having 1 to 35 carbon atoms.
  • pentosidine (formula 10):
  • AGEs Advanced Glycation End Products
  • aldose preferably selected from glucose, lactose, galactose and / or mannose.
  • deodorant or antiperspirant compositions are characterized in that the compound from the group of advanced glycation end products (AGEs) and / or their precursors is selected from reaction products of the reaction of at least one compound from the group of sugars, preferably selected from the aldoses , preferably selected from glucose, lactose, galactose and / or mannose, with at least one compound from the group of amino acids, preferably selected from lysine, hydroxylysine, arginine, tryptophan and / or histidine.
  • AGEs advanced glycation end products
  • amino acids preferably selected from lysine, hydroxylysine, arginine, tryptophan and / or histidine.
  • Preferred lysine-based AGEs of the invention and / or their precursors are furthermore products of the Maillard reaction of lysine A with sugars
  • examples of such substances according to the invention are ⁇ - ⁇ -fructosyllysine (fructoselysine) 12, ⁇ - ⁇ -carboxymethyllysine (CML) 13, carboxyethyl lysine (CEL) 14 or maltosine 15 and pyridosine 15a, which are characterized by the following structural formulas:
  • arginine-based AGEs are products of the Maillard reaction of arginine B with sugars; examples of such substances according to the invention are ornithinoimidazolinone 16, argpyrimidine 17, 3-deoxyglucosululose (3-DG) 18 or galactosylisomaltol 19, which can be mentioned characterized by the following structural formulas:
  • glycation products of lysine and arginine for example CML 20, CEL 21, pyrraline 22, DOLD 23, GOLD 24, MOLD 25, pentosidine 26, dihydroxyimidazolidine 27, glarg 28, CMA 29, imidazolone 30, MGO-imidazolone 31, 3-DG-imidazolone 32 or argopyrimidine 33, which are characterized by the following structural formulas:
  • deodorant or antiperspirant compositions according to the invention are preferred which contain at least one compound according to formula 2 to 33 inclusive 15a.
  • Particularly preferred deodorant or antiperspirant compositions according to the invention comprise - based on their weight - 0.00001 to 5 wt .-%, preferably 0.0001 to 3 wt .-%, particularly preferably 0.001 to 2 wt .-%, more preferably 0 , 01 to 1 wt .-% and in particular 0, 1 to 0.5 wt .-% Advanced Glycation End Products (AGEs) and / or their precursors.
  • AGEs Advanced Glycation End Products
  • a particularly preferred AGE is maltosine, which is particularly advantageously included in compositions of the invention.
  • extremely preferred deodorant or antiperspirant compositions contain, based on their weight, from 0.0001 to 5% by weight, preferably from 0.001 to 3% by weight, particularly preferably from 0.01 to 2% by weight preferably 0.1 to 1 wt .-% and in particular 0.25 to 0.5 wt .-% maltosine (formulas 15 / 15a).
  • cosmetically or dermatologically acceptable carrier is present as powder, in stick form, as aerosol spray, pump spray, liquid or gel-like roll-on application, cream, lotion, solution, gel or applied to a substrate.
  • Deodorant or antiperspirant sticks can be in gelled form, on an anhydrous basis, based on a W / O emulsion, based on an O / W emulsion, based on a water-oil multiple emulsion, based on a nanoemulsion and are based on a microemulsion, wherein the oil phase contain at least one silicone component or can consist of at least one silicone component.
  • the compositions according to the invention, which are formulated as deodorant or antiperspirant sticks can be prepared on anhydrous fat basis, based on a polyol-in-oil emulsion based on an oil-in-polyol emulsion based on a polyol oil.
  • Gel sticks can be prepared on the basis of fatty acid soaps, dibenzylidenesorbitol, N-acylamino acid amides, 12-hydroxystearic acid, polyamides, polyamide derivatives, polysaccharides such as xanthan, polyglucomanna- NEN, guar, Konjak, celluloses or starches, polyacrylates, polyacrylate derivatives and other gelling agents are formulated.
  • Aerosol sprays, pump sprays, roll-on applications and creams may be in the form of a water-in-oil emulsion, oil-in-water emulsion, silicone oil-in-water emulsion, water-in-oil microemulsion, oil-in Water-microemulsion, silicone oil-in-water microemulsion, polyol-in-oil emulsion, oil-in-polyol emulsion, polyol-oil multiple emulsion, anhydrous suspension, preferably anhydrous oil-based suspension, alcoholic solution, in particular ethanolic solution, hydroalcoholic solution, in particular solutions with more than 50 wt .-% of a water-ethanol mixture, glycolic solution, especially as a solution in propylene glycol, glycerol, dipropylene glycol and (under normal conditions) liquid polyethylene glycols, hydroglycolic solution, polyol solution , Water-polyol solution, aqueous gel, lipogel, and oil.
  • compositions may be thickened, for example based on fatty acid soaps, dibenzylidenesorbitol, N-acylamino acid amides, 12-hydroxystearic acid, carbomer-type polyacrylates, polyacrylamides and polysaccharides, which may be chemically and / or physically modified.
  • the compositions may be transparent, translucent or opaque. If the compositions according to the invention are in the form of a stick, they preferably contain a lipid or wax matrix comprising at least one lipid or wax component with a melting point> 50 ° C.
  • compositions according to the invention which are formulated as an emulsion, in particular as an oil-in-water or polyol-in-water emulsion, preferably comprise at least one nonionic oil-in-water emulsifier having an HLB value of more than 7
  • emulsifiers which are generally known to the person skilled in the art and are listed, for example, in Kirk-Othmer, "Encyclopedia of Chemical Technology", 3rd edition, 1979, Volume 8, pages 913-916.
  • Particularly preferred deodorant or antiperspirant compositions according to the invention comprise at least one nonionic oil-in-water emulsifier in a total amount of 0.5-10% by weight, more preferably 1-4% by weight and most preferably 1, 5 - 3 wt .-%, each based on the total composition.
  • compositions according to the invention which are formulated as an emulsion or stick, preferably furthermore comprise at least one nonionic water-in-oil emulsifier having an HLB value greater than 1.0, and less than or equal to 7.0, selected from the mono- and diesters of Ethylene glycol and the mono-, di-, tri- and tetra-esters of pentaerythritol with linear saturated fatty acids having 12-30, in particular 14-22 carbon atoms, which may be hydroxylated, and mixtures thereof, as consistency regulator and / or water binder.
  • the mono- and diesters are preferred.
  • preferred C 12 -C 3 o-fatty acid radicals are selected from lauric acid, myristic acid, palmitic acid, stearic acid, and behenic acid Arachinklare- radicals; particularly preferred is the stearic acid residue.
  • Preferred as additional water-in-oil emulsifier are:
  • linear saturated alkanols having 12 to 30 carbon atoms, in particular 16 to 22 carbon atoms, in particular cetyl alcohol, stearyl alcohol, arachidyl alcohol, behenyl alcohol and Lanolin alcohol or mixtures of these alcohols, as obtainable in the industrial hydrogenation of vegetable and animal fatty acids,
  • Such esters or partial esters are, for.
  • Sterols ie steroids which carry a hydroxyl group at the C3 atom of the steroid skeleton and both from animal tissue (zoosterols, eg cholesterol, lanosterol) as well as from plants (phytosterols, eg ergosterol, stigmasterol, sitosterol) and from fungi and yeasts (mycosterols) which may be low ethoxylated (1-5 EO);
  • Alkanols and carboxylic acids each having 8-24 C atoms, in particular having 16-22 C atoms, in the alkyl group and 1-4 ethylene oxide units per molecule which have an HLB value of greater than 1.0, and less than or equal to 7.0 exhibit,
  • Partial esters of polyglycerols with n 2 to 10 glycerol units and with 1 to 5 saturated or unsaturated, linear or branched, optionally hydroxylated C 8 - C 30 fatty acid residues esterified, if they have an HLB value of less than or equal to 7,
  • compositions according to the invention comprise mixtures, in particular technical mixtures, of at least two additional water-in-oil emulsifiers.
  • Particularly preferred deodorant or antiperspirant compositions according to the invention are characterized in that at least one water-in-oil emulsifier is present in a total amount of 0.1-15% by weight, preferably 0.5-8.0% by weight, and particularly preferably 1 to 4% by weight, based on the total composition, are contained. Furthermore, amounts of from 2 to 3% by weight, based on the total weight of the composition, according to the invention may also be extremely preferred.
  • compositions according to the invention are characterized in that the total content of nonionic and ionic emulsifiers and / or surfactants with an HLB value above 8 not more than 20 wt .-%, preferably at most 15 wt .-%, particularly preferably at most 10 wt .-% , more preferably at most 7 wt .-%, further particularly preferred not more than 4% by weight and, most preferably, not more than 3% by weight, based in each case on the total composition according to the invention.
  • compositions of the present invention which are in the form of an emulsion, suspension or stick, preferably further contain at least one oil which is liquid at 20 ° C and which is not a perfume component and does not constitute an essential oil.
  • preferred oils are selected from branched, saturated or unsaturated fatty alcohols having 6 - 30 carbon atoms, the triglycerides of linear or branched, saturated or unsaturated, optionally hydroxylated C 8 -3o fatty acids, dicarboxylic acid esters of linear or branched C 2 -C 0 - alkanols , the addition products of 1 to 5 propylene oxide units of mono- or polyhydric C 8 _22 alkanols such as octanol, decanol, decanediol, lauryl alcohol, myristyl alcohol and stearyl alcohol, eg.
  • PPG-2-myristyl ethers and PPG-3-myristyl ethers the esters of linear or branched saturated or unsaturated fatty alcohols having from 2 to 30 carbon atoms with linear or branched saturated or unsaturated fatty acids having from 2 to 30 carbon atoms which may be hydroxylated, in particular hexyldecyl stearate Hexyldecyl laurate, isodecyl neopentanoate, isononyl isononanoate, 2-ethylhexyl palmitate and 2-ethylhexyl stearate; the addition products of at least 6 ethylene oxide and / or propylene oxide units of mono- or polyhydric C 3 -22-alkanols such as butanol, butanediol, myristyl alcohol and stearyl alcohol, eg.
  • Eg dicopyryl carbonate the esters of dimers of unsaturated C 2 -C 2 2 -fatty acids (dimer fatty acids) with monovalent linear, branched or cyclic C 2 -C 8 -alkanols or with polyvalent linear or branched C 2 -C 6 -alkanols. It may be extraordinarily preferred according to the invention to use mixtures of the abovementioned oils. Further oil components preferred according to the invention are selected from silicone oils and hydrocarbon oils.
  • compositions according to the invention which are formulated as a water-in-oil emulsion, preferably further comprise at least one water-in-oil emulsifier.
  • the at least one water-in-oil emulsifier is preferably in an amount of 0.5 to 5 wt .-%, particularly preferably 1, 0 to 1, 5 to 2.5 wt .-%, each based on the total weight of Emulsion, included.
  • PEG / PPG-18/18 dimethicones which are commercially available in a 1: 9 mixture with cyclomethicone as DC 3225 C or DC 5225 C
  • PEG / PPG-4/12 dimethicone sold under the name Abil B 8852 is available as well as Bis-PEG / PPG-14/14 Dimethicone, which is commercially available in a mixture with Cyclomethicone as Abil EM 97 (Evonik)
  • Bis-PEG / PPG-20/20 Dimethicone under the name Abil B 8832 is available, PEG / PPG-5/3 trisiloxanes (Silsoft 305), and PEG / PPG-20/23 dimethicones (Silsoft 430 and Silsoft 440).
  • W / O emulsifiers are poly (C 2 -C 3) alkylene glycol-modified silicones, the 4 -C 8 alkyl groups are hydrophobically modified with C, more preferably cetyl PEG / PPG-10/1 Dimethicone (formerly Cetyl dimethicone copolyol, available as Abil EM 90 or in a mixture of polyglyceryl-4-isostearate, cetyl PEG / PPG-10/1 dimethicone and hexyl laurate under the trade name Abil WE 09), furthermore alkyl methicone copolyols and alkyl dimethicone ethoxy glucosides.
  • cetyl PEG / PPG-10/1 Dimethicone originally Cetyl dimethicone copolyol, available as Abil EM 90 or in a mixture of polyglyceryl-4-isostearate, cetyl PEG / PPG-10/1 dimethicone and
  • compositions according to the invention which are formulated as a propellant-driven aerosol, contain at least one propellant.
  • propellants are propane, propene, n-butane, isobutane, isobutene, n-pentane, pentene, isopentane, isopentene, methane, ethane, dimethyl ether, nitrogen, air, oxygen, nitrous oxide, 1, 1, 1, 3-tetrafluoroethane, heptafluoro-n-propane, perfluoroethane, monochlorodifluoromethane, 1, 1-difluoroethane, both individually and in combination.
  • hydrophilic propellants such.
  • hydrophilic gases can be used advantageously in the context of the present invention, when the proportion of hydrophilic gases is selected low and lipophilic propellant gas (eg., Propane / butane) is present in excess.
  • propellant gas eg., Propane / butane
  • propane, n-butane, isobutane and mixtures of these propellants propane, n-butane, isobutane and mixtures of these propellants. It has been found that the use of n-butane as the only propellant gas according to the invention can be particularly preferred.
  • the amount of blowing agent is preferably 20-80% by weight, more preferably 30-70% by weight and most preferably 40-50% by weight, based in each case on the total weight of the preparation, consisting of the composition according to the invention and the blowing agent.
  • compositions according to the invention also comprise at least one water-soluble polyhydric C 2 -C 9 -alkanol having 2-6 hydroxyl groups and / or at least one water-soluble polyethylene glycol having 3-20 ethylene oxide units and mixtures thereof. Surprisingly, it has been found that such compounds can further support the anti-irritative and soothing effect of the compositions according to the invention.
  • These components are preferably selected from 1,2-propylene glycol, 2-methyl-1,3-propanediol, glycerol, 1,2-butylene glycol, 1,3-butylene glycol, 1,4-butylene glycol, 1,2-pentanediol, 1, 5-pentanediol, 1, 2-hexanediol, 1, 6-hexanediol, 1, 2,6-hexanetriol, 1, 2-octanediol, 1, 8-octanediol, dipropylene glycol, tripropylene glycol, diglycerol, triglycerol, erythritol, sorbitol and mixtures of aforementioned substances.
  • Preferred water-soluble polyethylene glycols are selected from PEG-3, PEG-4, PEG-6, PEG-7, PEG-8, PEG-9, PEG-10, PEG-12, PEG-14, PEG-16, PEG-18 and PEG-20 and mixtures thereof, with PEG-3 to PEG-8 being preferred.
  • preferred deodorant or antiperspirant compositions comprise at least one water-soluble polyhydric C 2 -C 9 -alkanol having 2 to 6 hydroxyl groups and / or at least one water-soluble polyethylene glycol having 3 to 20 ethylene oxide units, selected from 1,2-propylene glycol, 2 -Methyl-1,3-propanediol, glycerol, 1,2-butylene glycol, 1,3-butylene glycol and 1,4-butylene glycol, 1,2-pentanediol, 1,5-pentanediol, 1,2-hexanediol, 1,6 -Hexanediol, 1, 2,6-hexanetriol, 1, 2-octanediol, 1, 8-octanediol, dipropylene glycol, tripropylene glycol, diglycerol, triglycerol, erythritol, sorbitol, and mixtures of the
  • Particularly preferred deodorant or antiperspirant compositions according to the invention comprise the at least one water-soluble polyhydric C 2 -C 9 -alkanol with 2-6 hydroxyl groups and / or the at least one water-soluble polyethylene glycol with 3-20 ethylene oxide units in total in amounts of 3-30% by weight .-%, preferably 8 - 25 wt .-%, particularly preferably 10 - 18 wt .-%, each based on the total composition.
  • compositions according to the invention contain water.
  • the proportion of water is preferably 0, 1-99 wt .-%, particularly preferably 3 to 80 wt .-%, most preferably 10 to 70 wt .-%, further preferably 15 - 60 wt .-%, 20 - 50 wt .-%, 30- 40 wt .-%, each based on the total composition.
  • perfume component perfumes perfume oils or perfume oil ingredients can be used.
  • perfume oils or fragrances can according to the invention individual fragrance compounds, eg. As the synthetic products of the ester type, ethers, aldehydes, ketones, alcohols and hydrocarbons. Fragrance compounds of the ester type are known e.g.
  • the ethers include, for example, benzyl ethyl ether and ambroxane, to the aldehydes e.g.
  • the linear alkanals having 8-18 C atoms citral, citronellal, citronellyloxy-acetaldehyde, cyclamen aldehyde, lilial and bourgeonal, to the ketones, e.g. the ionones, alpha-isomethylionone and methylcedryl ketone; the alcohols anethole, citronellol, eugenol, geraniol, linalool, phenylethyl alcohol and terpineol; the hydrocarbons mainly include the terpenes such as limonene and pinene.
  • Particularly preferred deodorant or antiperspirant compositions according to the invention contain at least one perfume component in a total amount of 0.00001 to 10 wt .-%, preferably 0.5 to 7 wt .-%, particularly preferably 1-5 wt .-%, each based on the overall composition.
  • a non-therapeutic, cosmetic method for regulating hair growth, in particular for reducing hair growth wherein a deodorant or antiperspirant composition according to the invention is topically applied in an effective amount is applied to the skin, in particular to the skin in the underarm area, and a non-therapeutic, cosmetic process for the treatment of body odor, in which a composition according to the invention is applied in an effective amount to the skin.
  • Another object of the present application is the use of a deodorant or antiperspirant composition according to the invention or preferred according to the invention for improving the skin compatibility in the non-therapeutic, cosmetic treatment of body odor and / or in the non-therapeutic, cosmetic regulation of hair growth.
  • compositions according to the invention applies mutatis mutandis.
  • compositions according to the invention show compositions according to the invention. All quantities are in wt .-%.
  • Cocoglycerides (FP 30-32 ° C) 5 4
  • Compositions 7.1 and 7.2 were filled in spray cans of internally painted aluminum and mixed with an isobutane / butane / propane propellant mixture in the weight ratio suspension: propellant of 25:75, 22:78, 20:80, 18:82, 15:85 and 13: 87.
  • compositions 8.2 and 8.2 according to the invention were filled into spray cans of aluminum painted on the inside and mixed with an isobutane / butane / propane blowing agent mixture in the weight ratio suspension: propellant of 25:75, 22:78, 20:80, 18:82, 15: 85 and 13: 87 charged.
  • Water-in-oil emulsion for administration as a spray (with propellant) (in% by weight)
  • Talc TALC 10 10 10 kappa carrageenan 0.5 - - Apple pectin 1.0 -

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Inorganic Chemistry (AREA)
  • Emergency Medicine (AREA)
  • Cosmetics (AREA)

Abstract

L'invention concerne des compositions déodorantes ou anti-transpirantes cosmétiques ou dermatologiques, pour soigner et apaiser la peau, contenant au moins un agent actif déodorant ou anti-transpirant et au moins un cyclohexanol substitué. L'efficacité des compositions selon l'invention peut être améliorée par addition d'au moins un adjuvant déodorant choisi dans les groupes des sels d'argent et/ou des complexes d'argent et/ou des minéraux d'origine volcanique et/ou des zéolithes et/ou de l'alun et/ou des agents actifs inhibant la croissance des poils. Les compositions selon l'invention possèdent un effet d'apaisement et de soin de la peau même après de longues durées de stockage, sans que leur effet de soin ne soit diminué par les agents actifs déodorants et anti-transpirants.
EP11711911.5A 2010-04-20 2011-04-04 Déodorants et anti-transpirants respectueux de la peau Withdrawn EP2680810A2 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE201010027947 DE102010027947A1 (de) 2010-04-20 2010-04-20 Hautschonende Deodorantien und Antitranspirantien
PCT/EP2011/055195 WO2011131474A2 (fr) 2010-04-20 2011-04-04 Déodorants et anti-transpirants respectueux de la peau

Publications (1)

Publication Number Publication Date
EP2680810A2 true EP2680810A2 (fr) 2014-01-08

Family

ID=44625631

Family Applications (1)

Application Number Title Priority Date Filing Date
EP11711911.5A Withdrawn EP2680810A2 (fr) 2010-04-20 2011-04-04 Déodorants et anti-transpirants respectueux de la peau

Country Status (3)

Country Link
EP (1) EP2680810A2 (fr)
DE (1) DE102010027947A1 (fr)
WO (1) WO2011131474A2 (fr)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104010525B (zh) 2011-12-21 2017-08-25 默克专利股份有限公司 环己醇衍生物作为抗菌抗微生物活性物质的用途
DE102012002592A1 (de) 2012-02-13 2013-08-14 Dr. Kurt Wolff Gmbh & Co. Kg Verwendung eines Mittels zur Stimulation der Gen-Expression antimikrobieller Peptide (AMP)
CN104271109A (zh) 2012-04-25 2015-01-07 默克专利股份有限公司 具有抗微生物性质的二环己基甲醇衍生物的用途
DE102012016194A1 (de) 2012-08-16 2014-03-13 Merck Patent Gmbh Verwendung von Dicyclohexylmethanolderivaten mit antimikrobiellen Eigenschaften
EP2846763B1 (fr) 2012-05-08 2017-02-08 Merck Patent GmbH Utilisation d'ethers de cyclohexanol antimicrobiens
DE102012016191A1 (de) 2012-08-16 2014-03-13 Merck Patent Gmbh Verwendung von Cyclohexanolethern mit antimikrobiellen Eigenschaften
US9155714B2 (en) 2013-06-06 2015-10-13 Johnson & Johnson Consumer Inc. Compositions comprising an aromatic alcohol and a TRPV-1 antagonist, and uses thereof
DE102015223846A1 (de) * 2015-12-01 2017-06-01 Henkel Ag & Co. Kgaa Verfahren zur Reduzierung des Schweißes und/oder Körpergeruchs unter Verwendung von speziellen Alkoholen

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19756454C1 (de) 1997-12-18 1999-06-17 Henkel Kgaa Verwendung von Glycerincarbonat
US20060115440A1 (en) * 2004-09-07 2006-06-01 Arata Andrew B Silver dihydrogen citrate compositions
WO2009087242A2 (fr) 2009-04-09 2009-07-16 Symrise Gmbh & Co. Kg Compositions comprenant du trans-tert-butyl cyclohexanol en tant qu'agent réduisant l'irritation cutanée

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See references of WO2011131474A2 *

Also Published As

Publication number Publication date
WO2011131474A2 (fr) 2011-10-27
WO2011131474A3 (fr) 2013-12-05
DE102010027947A1 (de) 2011-10-20

Similar Documents

Publication Publication Date Title
WO2011131474A2 (fr) Déodorants et anti-transpirants respectueux de la peau
WO2012080017A2 (fr) Compositions anti-transpirantes aqueuses à masquage amélioré des sels résiduels
DE102012222692A1 (de) Antibakterielles Kosmetikum
WO2008025698A1 (fr) Compositions anti-transpiration et déodorantes ayant une action de soin améliorée
WO2006128622A2 (fr) Compositions d'aerosol deodorantes contenant des huiles et des substances actives qui rafraichissent la peau
EP2934461B1 (fr) Sprays antitranspirants ménageant les textiles, contenant des acides hydroxycarboxyliques
EP2451426A2 (fr) Compositions cosmétiques contenant des suspensions de sels d'argent
WO2014095686A2 (fr) Antitranspirants non aérosols ménageant les textiles, contenant des acides hydroxycarboxyliques
WO2013041611A1 (fr) Formulations anhydres présentant un effet de refroidissement
DE102015225958A1 (de) Kosmetische Mittel, enthaltend eine Kombination von mindestens zwei verschiedenen Wirkstoffen
EP2370050B1 (fr) Nouveaux déodorants et anti-transpirants permettant d'inhiber la croissance pileuse
WO2009101000A2 (fr) Déodorants et/ou antitranspirants à fragrance et à capacité d'absorption d'odeurs à effet renforcé
EP3432855A1 (fr) Stick antitranspirant sous forme d'émulsion huile dans l'eau
DE102016220085A1 (de) geruchsreduzierende Körperpflegemittel
EP2059225A1 (fr) Compositions antitranspirantes et désodorisantes de potentiel irritatif réduit
WO2014187576A1 (fr) Association de principes actifs désodorisante
EP2934465A2 (fr) Sprays antitranspirants ménageant les textiles, contenant de l'acide méthane-sulfonique
DE102011088967A1 (de) Deodorants und Antitranspirants mit stabilisiertem Antioxidans
DE102011087980A1 (de) Deodorants und Antitranspirants mit Haar aufhellender Wirkung
WO2015055200A1 (fr) Agent cosmétique anti-transpiration contenant des acides alkylsulfoniques
DE102017215326A1 (de) Polyethylenimin mit geringem Molekulargewicht als Antitranspirantwirkstoff als O/W-Emulsion
DE102011089012A1 (de) Textilschonende Antitranspirantien
DE102009027483A1 (de) Deodorantien und Antitranspirantien mit haarwuchsminimierender oder -inhibierender Wirkung

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20121001

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

17Q First examination report despatched

Effective date: 20141223

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20151101